-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QBuBT5GfgnIWuAEFF6kgNte46Zipdyuf6oshJQ1xv91goUk+8ayQRIdco5lirePA fYpa9yuOryI+WCn/OMQUdQ== 9999999997-10-011750.txt : 20100521 9999999997-10-011750.hdr.sgml : 20100521 20100521135121 ACCESSION NUMBER: 9999999997-10-011750 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100521 DATE AS OF CHANGE: 20100521 20100521 20100521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trubion Pharmaceuticals, Inc CENTRAL INDEX KEY: 0001298521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-33054 FILM NUMBER: 10850471 BUSINESS ADDRESS: STREET 1: 2401 4TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2068380500 MAIL ADDRESS: STREET 1: 2401 4TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH-/#PO3&EN96%R:7IE9"`Q+TP@-SDR M,2]/(#@O12`S-CDY+TX@,2]4(#;@L=D[Z)8VJP%8!*B. M]SI4GQ40LS(PR*R'B#-\`P@P`#!^!^0-"F5N9'-T7!E+T-A=&%L M;V7!E+U!A9V4^/@UE;F1O8FH-.2`P(&]B:@T\/"]&;VYT/#PO5%0R(#$P M(#`@4B]45#0@,3(@,"!2/CXO4')O8U-E=%LO4$1&+U1E>'1=+T5X=$=3=&%T M93P\+T=3,2`Q-2`P(%(^/CX^#65N9&]B:@TQ,"`P(&]B:@T\/"]3=6)T>7!E M+U1R=654>7!E+T9O;G1$97-CDB9!;(KDW,:_-)#M$!W`9#4##!+0F/PYO9VL;LP#3._O M[I:;S?)^I=TG=,S.O$N?3#IWS0IKOLO>P&=#\#WFZ2I91,^-KO&)Z#B^2MB" MX!D0[M>S^1IN''>$A:\GJW2YNL'<5@N5%/-I&"(;UMHWUI&OK9>S.5I,?H=T M/9^D=_A@L$+#.+HJQ[>PRXCI[1PL6`C3W(`#DVD*]PM@XT!B[Y/0.$0>PD\J M98R&R9D:TJ;?BKJ"[_NL>BY+"J M*2`#;A!X\A"FBU_\B"6:`4;],YF1OS_Z41=1X*$6N,3&Z"@\A?8NL8HL]8QI MU,!Q_23R4#D7I3DC&I!3?4Z(!$>%[B_4ZZ MZ:N"-[#NL5(_W+J^QAL;R35YR.@-_]'SMA/5,^1UM1,%KSJ1E=`U/.MT!.ZX M&+OJ8%;$770E=#!@LGQNZL'3HBC;ED5*=C?-I$S'/_@!T26P"&E"T5ZXZB=H)< M:PNWCMIWSX1L*"'?LE8[:_BAX2U"HY!UI'Q;V+Z!84QM&-IDNKY'H^0$2'*D MW+3F.]EV>T>.HZRS*]&>D(Z(YE,CH7U?`!%:_]C1LK8??5:*G>`M9.TEJWG] M\L*;7"Z1RYU00L=Y%D=GHR#42599I2ZJ/.34BXG,QB?GZI(4+AK.BUJ?0;VS MC&FWQT1QI-B"F'$QR;LA1/!`-W1*(8K\)[)]>9^/.+P MD;32"T:F8G6@] MC?I$)_.!3H<(>]/V6:6DIU_]RLNGHZY`"I\S-?C[;E\WHGO[^LF0>[^P*"E" M\.>[A);)YL9%&""U+W(G4:K!'?Q?C91R(77!E M+U!A9V5S+TMI9'-;."`P(%)=/CX-96YD;V)J#30@,"!O8FH-/#PO4W5B='EP M92]834PO3&5N9W1H(#,V,30O5'EP92]-971A9&%T83X^G)E4WI.5&-Z:V,Y M9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM M<'1K/2)!9&]B92!835`@0V]R92`T+C`M8S,R,2`T-"XS.3@Q,38L(%1U92!! M=6<@,#0@,C`P.2`Q-#HR-#HS.2(^"B`@(#QR9&8Z4D1&('AM;&YS.G)D9CTB M:'1T<#HO+W=W=RYW,RYO&%P.D-R96%T;W)4;V]L/@H@("`@("`@("`\>&%P M.DUO9&EF>41A=&4^,C`Q,"TP-2TR,50Q,SHU,#HT-2TP-#HP,#PO>&%P.DUO M9&EF>41A=&4^"B`@("`@("`@(#QX87`Z0W)E871E1&%T93XR,#$P+3`U+3(Q M5#$S.C4P.C0U+3`T.C`P/"]X87`Z0W)E871E1&%T93X*("`@("`@/"]R9&8Z M1&5S8W)I<'1I;VX^"B`@("`@(#QR9&8Z1&5S8W)I<'1I;VX@&UL.FQA M;F<](G@M9&5F875L="(^36EC&%P34TZ26YS=&%N8V5)1#YU=6ED.F-F,6,S M9#0X+6(S-S&%P34TZ26YS=&%N M8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#POF4@-CX^#0IS=&%R='AR968-"C$Q-@T*)25%3T8- !"C\_ ` end -----END PRIVACY-ENHANCED MESSAGE-----